These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1293779)

  • 1. [Neoplasias of the erythrocyte series and related clonal pathology. Unified view and proposal for classification].
    Hernández Nieto L; Raya JM; Martínez Ibáñez MT
    Sangre (Barc); 1992 Oct; 37(5):383-90. PubMed ID: 1293779
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neutrophil alkaline phosphatase score].
    Nakamura Y; Waga K; Mitani K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():785-8. PubMed ID: 15658450
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of acute erythremia from myelodysplastic syndrome after treatment with 1,25-dihydroxyvitamin D(3).
    Kizaki M; Takayama N; Kawai Y; Okamoto S; Ikeda Y
    Am J Hematol; 2001 Jul; 67(3):215-6. PubMed ID: 11391727
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos.
    Tefferi A; Thiele J; Vardiman JW
    Cancer; 2009 Sep; 115(17):3842-7. PubMed ID: 19472396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T
    Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructural characteristics of bone marrow in patients with hematological disease: a study of 13 cases.
    Ru YX; Zhao SX; Liu EB; Yang QY; Liu JH; Pang TX; Chen HS
    Ultrastruct Pathol; 2007; 31(5):327-32. PubMed ID: 17963181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
    Rosati S; Anastasi J; Vardiman J
    Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
    [No Abstract]   [Full Text] [Related]  

  • 12. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
    Hyun BH; Gulati GL; Ashton JK
    Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J; Kvasnicka HM
    Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological abnormalities in erythroblasts and erythrocytes of acquired idiopathic dyserythropoietic anemia.
    Dreyfus B; Rochant H
    Haematologica; 1974 Jun; 59(2):221-30. PubMed ID: 4216534
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship of erythromonocytic leukemia to other myeloproliferative disorders.
    Shaw MT; Bottomley SS; Bottomley RH; Hussein KK
    Am J Med; 1973 Oct; 55(3):542-8. PubMed ID: 4355172
    [No Abstract]   [Full Text] [Related]  

  • 16. On the PAS reaction in acute paraerythroblastic hemoblastoses.
    Leder LD
    Acta Haematol; 1969; 41(6):328-30. PubMed ID: 4187960
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythroleukemia and myelodysplastic syndromes: an historical appraisal and a personal view.
    Michiels JJ
    Leuk Lymphoma; 1993 Jan; 9(1-2):27-34. PubMed ID: 8477198
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
    Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.